Edgewise Therapeutics Reports Third Quarter Financial Results and Business Highlights
Edgewise Therapeutics, Inc., a prominent biopharmaceutical company specializing in muscle disease, recently disclosed its financial results for the third quarter ending September 30, 2024. In a press release on November 7, 2024, the company highlighted various advancements in its clinical programs. The company is making significant progress in its muscular dystrophy program, particularly focusing on […]
More Stories
ZoomInfo Technologies (NASDAQ:ZI) Releases Q4 2024 Earnings Guidance
ZoomInfo Technologies (NASDAQ:ZI – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Tuesday morning....
eGain (NASDAQ:EGAN) Releases FY 2025 Earnings Guidance
eGain (NASDAQ:EGAN – Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company...
Wolverine World Wide, Inc. (NYSE:WWW) Insider Sells $205,403.54 in Stock
Wolverine World Wide, Inc. (NYSE:WWW – Get Free Report) insider Amy M. Klimek sold 10,214 shares of Wolverine World Wide...
Direxion Daily MSFT Bull 2X Shares (NASDAQ:MSFU) Short Interest Update
Direxion Daily MSFT Bull 2X Shares (NASDAQ:MSFU – Get Free Report) was the recipient of a large increase in short...
NWTN Inc. (NASDAQ:NWTN) Short Interest Up 204.1% in October
NWTN Inc. (NASDAQ:NWTN – Get Free Report) saw a large increase in short interest during the month of October. As...
Marblegate Acquisition Corp. (NASDAQ:GATE) Short Interest Up 525.0% in October
Marblegate Acquisition Corp. (NASDAQ:GATE – Get Free Report) was the target of a significant increase in short interest during the...